TGFBI and corneal dystrophy: When combined with more conventional in vitro cell manipulation approaches, these new tools may not only facilitate the identification of both the cellular function of TGFBI and signaling pathways critical for corneal dystrophy diseases but also provide new treatment options for patients suffering from this disease.